Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab in Kidney Transplant Recipients with De Novo Anti-HLA Antibodies
NCT00307125Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Mar 2006
- Primary completion
- Dec 2012
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of rituximab in kidney transplant rejection, sponsored by National Institute of Allergy and Infectious Diseases. Started Mar 2006; status: completed.
02
Drugs
rituximab
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT00307125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00307125.